The Loss of an NF Legend: Dr. Vincent Riccardi

We are deeply saddened by the passing of Dr. Vincent “Vic” Riccardi, a pioneering expert in neurofibromatosis (NF) research and a founder of the Texas Neurofibromatosis Foundation. Our heartfelt condolences go out to his family, friends, and colleagues.

Dr. Riccardi’s contributions over a career of more than 40 years were groundbreaking. He wrote many important papers and books that shaped NF research and treatment. As one of the first to specialize in NF, he laid the foundation for modern diagnosis and treatment approaches, significantly impacting the lives of people with NF and providing hope to them and their families.

He founded The Neurofibromatosis Institute in 1980 and set up a top clinic for patient care. Beyond his research, Dr. Riccardi was known for his compassion and willingness to help, offering support and advice to patients and fellow researchers.

A mentor and friend to many, Dr. Riccardi inspired a new generation of NF researchers, and his legacy is reflected in their continued work. Dr. Riccardi was dedicated to NF and especially the NF community until the end. His creativity, passion, determination, and dedication will be greatly missed.

Recent Posts

  • Where Belonging Can Lead: Rachel’s Journey with NF Midwest 

    Rachel was 13 when she first attended Camp NF.  At an age when so much was changing, camp gave her something she deeply needed: the chance to meet other young people who understood life with NF.  “NF camp gave me the opportunity to connect with others who had a shared experience and come to understand... Read More
  • McKenna Had an Idea. A Few Weeks Later, More Than 100 People Showed Up! 

    McKenna Smith had been thinking about doing something for the NF community. She wanted more people to understand NF, and she wanted to raise funds to help individuals and families find care, resources, support, and connection.  Then she saw NF Midwest’s Walk Your Way campaign and sent us a message.  From there, McKenna got to... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *